A randomized, controlled trial comparing twiee-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine hagedorn (NPH) therapy in newly diagnosed type 1 diabetes

Krishnavathana Hassan, Luisa M. Rodriguez, Susan E. Johnson, Susanne Tadlock, Rubina A. Heptulla

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized, controlled trial comparing twiee-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine hagedorn (NPH) therapy in newly diagnosed type 1 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences